424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2026-01-27 · 0001062993-26-000441
FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows 424B3 and supplements the active offering with updated prospectus details.
Common Shares · Exchange Nasdaq · Ticker FLGC · Underwriters R.F. Lafferty & Co., Inc.
2026-01-27 · 0001062993-26-000442
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows FWP and confirms the priced prospectus.
Common Shares of the Company, no par value per share · Exchange Nasdaq · Ticker FLGC · Use of proceeds Proceeds will be used to advance AI-focused asset management strategy and working capital · Underwriters R.F. Lafferty & Co., Inc.
2026-01-27 · 0001062993-26-000448
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-01-26 · 9999999995-26-000300
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2025-12-10 · 9999999995-25-003646
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B5 in the pre-IPO sequence.
6,300,000 shares
Common · Exchange Nasdaq Capital Market · Ticker FLGC · Selling stockholders only · Use of proceeds Acquisition of 0G and general corporate purposes · Underwriters White Lion Capital LLC
2025-11-28 · 0001062993-25-017068
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Gross proceeds $3,450,000
Common Shares, no par value · Exchange Nasdaq · Ticker FLGC · Underwriters Revere Securities LLC
2025-09-29 · 0001062993-25-015843
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Gross proceeds $2,120,000
Common · Exchange Nasdaq · Ticker FLGC · Use of proceeds General corporate purposes
2025-09-23 · 0001062993-25-015752
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2025-05-22 · 9999999995-25-001717
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2025-03-28 · 9999999995-25-000838
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Price $1.25 · 2,850,000 shares · Gross proceeds $3,562,500
Common Shares · Exchange Nasdaq Capital Market · Ticker FLGC
2024-12-16 · 0001062993-24-020628
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Gross proceeds $0.00
Common Shares · Underwriters Aegis Capital Corp.
2024-12-12 · 0001062993-24-020549
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2024-05-02 · 9999999995-24-001362
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
2,463,636 shares · Gross proceeds $3,794,000
common shares, no par value · Exchange Nasdaq · Ticker FLGC · Use of proceeds general corporate purposes · Underwriters AEGIS CAPITAL CORP.
2024-04-26 · 0001062993-24-008895
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $1.90 · 1,700,000 shares · Gross proceeds $3,230,000
common shares, no par value · Exchange Nasdaq · Ticker FLGC · Use of proceeds Proceeds to the company before expenses are approximately $3,093,675 · Underwriters AEGIS CAPITAL CORP.
2024-04-05 · 0001062993-24-008104
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Common Shares · Exchange Nasdaq · Ticker FLGC · Pre-funded warrants to purchase common shares · Use of proceeds Proceeds to be used for general corporate purposes · Underwriters AEGIS CAPITAL CORP.
2024-04-04 · 0001062993-24-008034
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2023-10-26 · 9999999995-23-003101
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B5 in the pre-IPO sequence.
2023-10-18 · 0001062993-23-019529
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $2.00 · 1,369,000 shares · Gross proceeds $2,738,000
Common Shares · Exchange Nasdaq Capital Market · Ticker FLGC · Common Share and Investor Warrant · Investor warrants to purchase 1,369,000 common shares at $2.50, exercisable after 6 months, 5.5-year term; placement agent warrants for 54,760 shares at $2.39 · Use of proceeds Capital expenditures, increasing operating capacity, working capital, and other general corporate purposes · Underwriters A.G.P./Alliance Global Partners
2023-09-20 · 0001062993-23-018341
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2023-09-06 · 9999999995-23-002584
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $0.40 · 12,500,000 shares · Gross proceeds $5,000,000
Common · Exchange Nasdaq Capital Market · Ticker FLGC · Investor Warrants to purchase 12,500,000 common shares at $0.40, Placement Agent Warrants to purchase 500,000 common shares at $0.44 · Use of proceeds Working capital and general corporate purposes · Underwriters A.G.P./Alliance Global Partners
2022-12-09 · 0001477932-22-009200
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 20-F and marks the registration effective.
2022-10-05 · 9999999995-22-002941
20-F
supplemental
20-F
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B4 in the pre-IPO sequence.
2022-05-09 · 0001477932-22-003099
424B4
priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $3.00 · 10,000,000 shares · Gross proceeds $30,000,000
Common Share · Exchange NASDAQ · Ticker FLGC · Over-allotment 1,500,000 · each Unit consists of one Common Share and one-half Unit Warrant · Unit Warrants exercisable at $3.75 per Common Share, exercisable immediately, expire 5 years from issuance · Underwriters A.G.P., BMO Capital Markets, Roth Capital Partners
2021-11-22 · 0001594062-21-000141
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1 filing.
Gross proceeds $53,130,000
Common Shares · Each unit consists of one Common Share and one-half of one Unit Warrant · Unit Warrants and Underwriters’ Warrants · Flags units, warrants
2021-11-18 · 0001594062-21-000138
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows F-1/A and marks the registration effective.
2021-11-18 · 9999999995-21-004411
F-1
filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Price $4.80 · 7,187,500 shares · Gross proceeds $34,500,000
Common Share · Exchange NASDAQ Capital Market · Ticker FLGC · Over-allotment 937,500 · Each Unit consists of one Common Share and one-half of one Unit Warrant · Unit Warrants exercisable at $______ per share, expiring five years from issuance; Underwriters’ Warrants exercisable at 110% of public price, exercisable after one year, terminating six years from effective date · Use of proceeds Proceeds will be used for working capital and general corporate purposes · Flags units, warrants · Underwriters A.G.P.
2021-11-16 · 0001594062-21-000135
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
2021-11-03 · 0001594062-21-000126
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after 424B4.
2021-10-05 · 0001594062-21-000124
424B4
priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows CERT and confirms the priced prospectus.
Price $5.00 · 3,333,333 shares · Gross proceeds $19,166,665
Common · Exchange NASDAQ · Ticker FLGC · Over-allotment 500,000 · Underwriters Boustead Securities, LLC
2021-05-12 · 0001594062-21-000074
CERT
inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows EFFECT in the pre-IPO sequence.
2021-05-11 · 0001354457-21-000552
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Price $4.50 · 5,806,133 shares · Gross proceeds $17,250,000
Common Shares · Underwriters’ warrants to purchase up to 268,333 common shares at an exercise price of $5.63, exercisable upon issuance · Flags warrants
The current filing represents Amendment No. 6 to Flora Growth Corp.'s F-1 registration statement, primarily adding Exhibit 5.1 without substantive changes to the prospectus. The filing registers 3,833,333 common shares and 268,333 common shares underlying underwriters' warrants, with an assumed offering price of $4.50 per share. The company remains an emerging growth company and seeks to list on NASDAQ under the symbol 'FLGC.'
2021-05-10 · 0001594062-21-000070
8-A12B
effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows F-1/A and registers the class of securities for exchange listing.
Flora Growth Corp. is registering common shares for listing on The Nasdaq Stock Market LLC via Form 8-A12B, referencing its prior F-1/A registration statement. The filing incorporates by reference the share capital description from the earlier prospectus, indicating a transition to public trading under Section 12(b) of the Exchange Act.
2021-05-10 · 0001594062-21-000071
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 8-A12B and marks the registration effective.
The filing confirms the effectiveness of Flora Growth Corp.'s securities registration under Form F-1, transitioning from the previous 8-A12B filing. The notice outlines the registration of common shares with no par value, referencing the prospectus included in the Registration Statement on Form F-1.
2021-05-10 · 9999999995-21-001858
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Price $4.50 · Range $4.00 to $5.00 · 3,833,333 shares · Gross proceeds $17,250,000
Common · Exchange NASDAQ Capital Market · Ticker FLGC · Over-allotment 500,000 · Underwriters’ warrants to purchase 7% of common shares at 125% of public price · Use of proceeds Proceeds to be used for general corporate purposes · Flags foreign_private_issuer, warrants
Flora Growth Corp. is conducting an initial public offering (IPO) of 3,333,333 common shares, with an additional 500,000 shares available under the underwriters' over-allotment option. The offering price is set at $4.50 per share, with proceeds intended for general corporate purposes. The company, an emerging growth company, is seeking NASDAQ listing under the symbol 'FLGC,' though approval is not guaranteed. The offering is structured on a firm commitment basis, with Boustead Securities, LLC as the lead underwriter.
2021-05-05 · 0001594062-21-000068
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Price $4.50 · Range $4.00 to $5.00 · 3,833,333 shares · Gross proceeds $17,250,000
Common Shares, no par value · Exchange NASDAQ Capital Market · Ticker FLGC · Over-allotment 500,000 · Underwriters' warrants to purchase up to 7% of common shares at 125% of public price · Use of proceeds Proceeds to be used for general corporate purposes · Flags foreign_private_issuer, warrants
Flora Growth Corp. is conducting an initial public offering (IPO) of 3,333,333 common shares, with an additional 500,000 shares available via underwriters' over-allotment option. The offering price is estimated between $4.00 and $5.00 per share, with a midpoint of $4.50. The filing includes a Public Offering Prospectus and a separate Resale Prospectus for selling shareholders. The company, an emerging growth company, seeks to list on NASDAQ under the symbol 'FLGC,' though approval is not guaranteed. Proceeds will fund operations, with underwriting discounts and commissions totaling $1,035,000.
2021-04-21 · 0001594062-21-000052
FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows F-1/A and supplements the active offering with updated prospectus details.
Flora Growth Corp. is conducting an initial public offering (IPO) of 3,333,333 common shares, with an additional 500,000 shares available if underwriters exercise their over-allotment option. The offering price is estimated between $4.00 and $5.00 per share. The filing includes a public offering prospectus and a separate resale prospectus for existing shareholders, detailing the use of proceeds, underwriting terms, and risk factors. The company is an emerging growth company and seeks NASDAQ listing under the symbol 'FLGC.'
2021-04-21 · 0001594062-21-000054
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Price $4.50 · Range $4.00 to $5.00 · 3,833,333 shares · Gross proceeds $17,250,000
Common Shares (1)(2) · Exchange NASDAQ Capital Market · Ticker FLGC · Over-allotment 500,000 · Underwriters' warrants to purchase up to 7% of common shares at 125% of public offering price · Use of proceeds Proceeds will be used for working capital, debt repayment, and general corporate purposes · Flags foreign_private_issuer, warrants
Flora Growth Corp. is conducting an initial public offering (IPO) of 3,333,333 common shares at an estimated price range of $4.00 to $5.00 per share, with an additional 500,000 shares available via the underwriters' over-allotment option. The offering is structured as a firm commitment underwriting, with Boustead Securities, LLC as the lead underwriter. The company, an emerging growth company, is seeking NASDAQ listing under the symbol 'FLGC,' though approval is not guaranteed. The filing includes a resale prospectus for existing shareholders and details underwriters' warrants exercisable at 125% of the public offering price.
2021-03-22 · 0001594062-21-000040
FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows F-1/A and supplements the active offering with updated prospectus details.
ZeroStack Corp. is conducting an initial public offering (IPO) of 3,333,333 common shares, with an additional 500,000 shares available via underwriter over-allotment options. The offering price is estimated between $4.00 and $5.00 per share, with a midpoint of $4.50. The company, organized under Ontario law, is an emerging growth company seeking NASDAQ listing under the symbol 'FLGC.' No public market exists for its shares prior to this offering.
2021-03-19 · 0001594062-21-000038
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Price $4.50 · Range $4.00 to $5.00 · 3,833,333 shares · Gross proceeds $17,250,000
Common Shares, no par value · Exchange NASDAQ · Ticker FLGC · Over-allotment 500,000 · Underwriters’ warrants to purchase up to 7% of common shares at 125% of public price · Use of proceeds Proceeds to be used for working capital and general corporate purposes · Flags foreign_private_issuer, warrants
Flora Growth Corp. is conducting an initial public offering (IPO) of 3,333,333 common shares at an estimated price range of $4.00 to $5.00 per share, with an additional 500,000 shares available via underwriters' over-allotment options. The offering is being underwritten by Boustead Securities, LLC. The company, organized under Ontario law, is an emerging growth company seeking to list on NASDAQ under the symbol 'FLGC,' though approval is not guaranteed. The filing includes a Resale Prospectus for selling shareholders and outlines risks related to market volatility, regulatory uncertainties, and the speculative nature of the investment.
2021-03-11 · 0001594062-21-000035
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1 filing.
Common Shares, no par value · Exchange NASDAQ Capital Market · Ticker FLGC · Underwriters’ warrants to purchase up to 7% of common shares at 110% of public offering price · Selling stockholders only · Use of proceeds Proceeds from resale by selling stockholders · Flags foreign_private_issuer
Flora Growth Corp. is conducting an initial public offering (IPO) of its common shares, with the filing serving as an amendment (F-1/A) to its initial registration statement. The offering is on a firm commitment basis, led by underwriter Boustead Securities, LLC. The company, organized under Ontario law, is an emerging growth company eligible for reduced reporting requirements. The IPO seeks to list shares on NASDAQ under the symbol 'FLGC,' though approval is not guaranteed. The offering includes underwriters' warrants and involves risks related to market uncertainty, regulatory compliance, and the speculative nature of the investment.
2021-03-03 · 0001594062-21-000033
F-1
filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
Common Shares (1)(2) · Exchange NASDAQ Capital Market · Ticker FLGC · Underwriters’ warrants to purchase up to 7% of common shares at 110% of public offering price · Use of proceeds For general corporate purposes · Flags foreign_private_issuer, warrants · Underwriters Boustead Securities, LLC
Flora Growth Corp. (ZeroStack Corp.) is conducting an initial public offering (IPO) of common shares, with the filing indicating an emerging growth company status under U.S. securities laws. The offering is underwritten by Boustead Securities, LLC, with shares priced at an undisclosed amount. The company seeks to list on NASDAQ under the symbol 'FLGC,' though approval is not guaranteed. The filing highlights significant risks, including lack of a public market for shares, uncertainty around NASDAQ listing, and speculative nature of the investment.
2021-02-11 · 0001594062-21-000018
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Flora Growth Corp. (formerly ZeroStack Corp.) has submitted a confidential draft registration statement (DRS) for an initial public offering (IPO) of common shares, seeking to list on NASDAQ under the symbol 'FLGC'. The offering is structured on a firm commitment basis with Boustead Securities, LLC as the lead underwriter. The company, an emerging growth company, lacks a public market for its shares and faces uncertainties around NASDAQ approval. The filing emphasizes speculative risks, including market volatility, regulatory challenges, and limited operating history.
2020-12-31 · 0001594062-20-000143